Advertisement

Risk of Transfusion-Transmitted Infection: A Comparative Analysis of Then and Now

  • H. J. Alter
Chapter
Part of the Developments in Hematology and Immunology book series (DIHI, volume 34)

Abstract

The past 15 years have witnessed remarkable advances in the prevention of transfusion-transmitted infections including the sequential introduction of donor screening assays for HIV and HCV, the advent of solvent detergent and other technologies for the sterilisation of plasma, intensified and more uniform donor questionnaires, increased FDA oversight and the demanding dictates of “Good Manufacturing Practices and most recently, the introduction of genomic amplification techniques (GAT) to narrow the infectious window for the most serious blood-transmitted viruses. To place these advances into perspective, prior to HIV testing in the spring of 1985, 8038 cases of transfusion-transmitted AIDS were reported in adults and 374 in children. In the 14 years since the first anti-HIV assays became available, there have been only 37 cases of transfusion-associated AIDS reported in adults and 2 in children; most of these cases occurred during the first generation of HIV assays and transmission is now an exceedingly rare event estimated to occur at a frequency of one case per 676,000 transfusions.

Keywords

Fulminant Hepatitis Representational Difference Analysis Posttransfusion Hepatitis Eclipse Phase Cryptogenic Chronic Liver Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected References

Transfusion-Associated Hepatitis

  1. 1.
    Alter HJ. Posttransfusion hepatitis in the United States, p.551. In: Nishioka K, Suzuki H, Mishiro S, Oda T (eds). Viral Hepatitis and Liver Disease. SpringerVerlag, Tokyo, 1994.CrossRefGoogle Scholar
  2. 2.
    Alter HJ, Seeff LB. Transfusion-Associated Hepatitis. In: Zuckerman A & Thomas H (eds). Viral Hepatitis (2nd edition). W.B. Saunders Co., LTD, London, 1998, pp. 1–25.Google Scholar

Hepatitis G Vims/GB Virus-Type C. Discovery and Molecular Biology

  1. 1.
    Simons JN, Leary TP, Lawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564–69.PubMedCrossRefGoogle Scholar
  2. 2.
    Linnen J, Wages J, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996,271: 505–08.PubMedCrossRefGoogle Scholar
  3. 3.
    Simons JN, Desai SM, Schuitz DE, et al. Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization. Virol 1996–70:6126–35.Google Scholar
  4. 4.
    Okamoto H, Nakao H, Inoue T, et al. The entire nucleotide sequences of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan. J Gen Virol 1997; 78:737–45.PubMedGoogle Scholar

Hepatitis G Vims/GB Virus-Type C. Antibody and Persistence

  1. 5.
    Tacke M, Schmolke S, Schlueter V, et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997;26:1626–33.PubMedCrossRefGoogle Scholar
  2. 6.
    Tanaka E, Kiyosawa K, Shimoda K, et al. Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis. J Virol Hep 1998;5:153–59.CrossRefGoogle Scholar
  3. 7.
    Thomas DL, Nakatsuji Y, Shih JW, Alter HJ, et al. Persistence and clinical significance of hepatitis G virus infections in injecting drug users. J Infect Dis 1997; 176 586–92.PubMedCrossRefGoogle Scholar

Hepatitis G Vims/GB Virus-Type C. Transfusion-Associated and Community-Acquired Hepatitis

  1. 8.
    Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997,349: 318–20.Google Scholar
  2. 9.
    Alter MJ, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997;336:741–46.PubMedCrossRefGoogle Scholar
  3. 10.
    Wang JT, Tsai FC, Lee CZ, et al. A prospective study of transfusion-transmitted GB virus C infections: similar frequency but different clinical presentation compared with hepatitis C vims. Blood 1996;8:1881–86.Google Scholar

Hepatitis G Vims/GB Virus-Type C. Transmission

  1. 11.
    Kao JH, Liu CJ, Chen PJ, et al. Interspousal transmission of GB virus C/hepatitis G virus: a comparison with hepatitis C virus. J Med Virol 1997;53:348–53.PubMedCrossRefGoogle Scholar
  2. 12.
    Viazov S, Riffelmann M, Sarr S, et al. Transmission of GBV-C/HGV from drug-addicted mothers to their babies. J Hepatol 1997;27:85–90.PubMedCrossRefGoogle Scholar
  3. 13.
    Zanetti AR, Tanzi E, Romano L, et al. Multicenter trial on mother-to-infant transmission of GBV-C virus. The Lombardy Study Group on Vertical/Perinatal Hepatitis Viruses Transmission. J Med Virol 1998:54:107–12.PubMedCrossRefGoogle Scholar

Hepatitis G Vims/GB Virus-Type C. Fulminant hepatitis

  1. 14.
    Hadziyannis SJ, fulminant hepatitis and the new G/GBV-C flavivirus. Journal of Viral Hepatitis 1997;4:15–19CrossRefGoogle Scholar
  2. 15.
    Wright TL, Hsu H, Donegan E et al: Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med 1991;115:111–12.PubMedCrossRefGoogle Scholar

Hepatitis G Vims/GB Virus-Type C. Hepatitis-Associated Aplastic Anaemia

  1. 16.
    Brown KE, Wong S, Young NS. Prevalence of GBV-C/HGV, a novel ‘hepatitis’ virus, in patients with aplastic anaemia. Br J Haematol 1997;97:492–96.PubMedCrossRefGoogle Scholar

Hepatitis G Vims/GB Virus-Type C. Cryptogenic (non-A-E) hepatitis and HCC

  1. 17.
    Zhang XH, Shinzawa H, Shoa L, et al. Detection of hepatitis G virus RNA in patients with hepatitis B, hepatitis C, and non-A-E hepatitis by RT-PCR using multiple primer sets. J Med Virol 1997;52:385–90.PubMedCrossRefGoogle Scholar
  2. 18.
    Laskus T, Wang LF, Radkowski M, et al. Hepatitis G virus infection in American patients with cryptogenic cirrhosis: no evidence for liver replication. J Infect Dis 1997;176:1491–95.PubMedCrossRefGoogle Scholar
  3. 19.
    Lightfoot K, Skelton M, Kew MC, et al. Does hepatitis GB virus-C infection cause hepatocellular carcinoma in black Africans? Hepatology 1997;26:740–42.PubMedCrossRefGoogle Scholar
  4. 20.
    Guilera M, S’aiz JC, L’opez-Labrador FX, et al. Hepatitis G virus infection in chronic liver disease. Gut 1998;42:107–11PubMedCrossRefGoogle Scholar
  5. 21.
    Tagger A, Donato F, Ribero ML, et al. A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC Study. Hepatology 1997;26:1653–57.PubMedGoogle Scholar
  6. 22.
    Hollingsworth RC, Minton EJ, Fraser-Moodie C, et al. Hepatitis G infection: role in cryptogenic chronic liver disease and primary liver cell cancer in the UK. J Viral Hep 1998;5:165–69.CrossRefGoogle Scholar
  7. 23.
    Sugai Y, Nakayama H, Fukuda M, et al. Infection with GB virus C in patients with chronic liver disease. J Med Virol 1997;51:175–81.PubMedCrossRefGoogle Scholar
  8. 24.
    Colombatto P, Ranone A, Civitico G, et al. A new hepatitis C virus-like flavi virus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatase serum levels. J Viral Hep 1997;4(supp l):55–60.CrossRefGoogle Scholar
  9. 25.
    Feucht HH, Zollner B, Polywka S, et al. Prevalence of hepatitis G viremia among healthy subjects, individuals with liver disease and persons at risk for parenteral transmission. J Clin Microbiol 1997;35:767–68.PubMedGoogle Scholar

Hepatitis G Vims/GB Virus-Type C. HGV-HCV Coinfection

  1. 26.
    Pawlotsky JM, Roudot-Thoraval F, Muerhoff AS, et al. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alpha therapy. J Med Virol 1998;54: 26–37.PubMedCrossRefGoogle Scholar
  2. 27.
    Tanaka E, Alter HJ, Nakatsuji Y, et al. Effects of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996;125:740–43.PubMedCrossRefGoogle Scholar

Hepatitis G Vims/GB Virus-Type C. Post-Transplantation

  1. 28.
    Karayiannis P, Blind AM, Pickering J, Hepatitis G virus does not cause significant liver disease after liver transplantation. J Viral Hep 1998;5:35–42.CrossRefGoogle Scholar
  2. 29.
    Berenguer M, Terrault NA, Piatak M, et al. Hepatitis G virus infection is patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996;111:1569–75.PubMedCrossRefGoogle Scholar
  3. 30.
    Hoofnagle JH, Lombardero M, Wei Y, et al. Hepatitis G virus infection before and after liver transplantation. Liver Transpl Surg 1997;3:578–85.PubMedCrossRefGoogle Scholar

Hepatitis G Vims/GB Virus-Type C. Chimpanzee Studies

  1. 31.
    Bukh J, Kim JP, Govindarajan S, et al. Experimental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus. J Infect Dis 1998;177:855–62.PubMedCrossRefGoogle Scholar
  2. 32.
    Krawczynski K. Novel hepatitis agents: the significance of clinical and experimental studies. An overview. J Gastroenterol Hepatol 1997;12:S193.CrossRefGoogle Scholar

Hepatitis G Vims/GB Virus-Type C. Replication in Liver

  1. 33.
    Saito S, Tanaka K, Kondo M, et al. Plus and Minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells. Biochem Biophys Research Communication. 1997;237:288–91.CrossRefGoogle Scholar
  2. 34.
    Kanda T, Yokosuka 0, Tagawa M, et al. Quantitative analysis of GBV-C RNA in liver and serum by strand-specific reverse transcription-polymerase chain reaction. J Hepatol 1998;29:707–14.PubMedCrossRefGoogle Scholar
  3. 35.
    Laskus T, Radkowski M, Wang LF, et al. Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol 1997;71:7804–06.PubMedGoogle Scholar
  4. 36.
    Pessoa MG, Terrault NA, Detmer J, et al. Quantitation of G and C virus in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 1998;27:877–80.PubMedCrossRefGoogle Scholar
  5. 37.
    Mushahwar IK, Erker JC, Muerhoff AS, et al. Tissue tropism of GBV-C and HCV in immunocompromised patients and protective immunity of antibodies to GB virus C second envelope (GBV-C E2) glycoprotein. Hepatologia Clinica 1998;6(Suppl 1):23.Google Scholar

TT Virus

  1. 38.
    Nishizawa T, Okamoto H, Konishi K, et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown aetiology. Biochem Biophys Research Communications 1997;241:92–97.CrossRefGoogle Scholar
  2. 39.
    Okamoto H, Nishizawa T, Kato N, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown aetiology. Hepatology Research 1998;10:1–6.CrossRefGoogle Scholar
  3. 40.
    Simmonds P, Davidson F, Lycett C, et al. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 1998;352:191–95.PubMedCrossRefGoogle Scholar
  4. 41.
    Naoumov NV, Petrova EP, Thomas MG, Williams R. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 1998;352:195–97.PubMedCrossRefGoogle Scholar
  5. 42.
    Okamoto H, Ak-ahane Y, Ukita M, et al. Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis. J Med Virol 1998;56: 128–32.PubMedCrossRefGoogle Scholar
  6. 43.
    Matsumoto A, Yeo AET, Sliih JW-K, Tanaka E, Kiyosawa K, Alter HJ. Transfusion-Associated TT Virus infection and its relationship to Liver Disease. Hepatology (in Press, 1999).Google Scholar

Transfusion Risk And Risk Reduction Strategies

  1. 44.
    Schreiber GB, Busch MP, Kleinman SH, Korelitz J. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685–89.PubMedCrossRefGoogle Scholar
  2. 45.
    Busch MP, Straemer SL, Kleinman SH. Evolving Applications of Nucleic Acid Amplification Assays for Prevention of Virus transmission by Blood Components and derivatives, hi: Garraty G (ed). Application of Molecular Biology to Blood Transfusion Medicine. Bethesda, MD, American Association of Blood Banks, 1997:123–76.Google Scholar
  3. 46.
    sStramer SL, Porter RA, Brodsky JP, et al. Sensitivity of HIV and HCV RNA Detection by pooled genome amplification testing (GAT). Vox Sang 1998;74(suppl l):abstract 1102.Google Scholar
  4. 47.
    Lin L, Cook D, Weisehahn G, et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and ultraviolet A light. Transfusion 1997;37:423–35.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1999

Authors and Affiliations

  • H. J. Alter
    • 1
  1. 1.Department of Transfusion Medicine, Warren Grant Magnuson Clinical CenterNational Institutes of HealthBethesdaUSA

Personalised recommendations